Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2; this is a minor technical update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page shows a minor revision tag updated from v3.4.0 to v3.4.1, likely in the footer. This change does not alter study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, indicating a minor site update or bug fix with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a 'Show glossary' option and updated metadata fields, including 'Last Update Submitted that Met QC Criteria' and the page revision to v3.4.0. Removed older wording and items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the previous revision note v3.3.4.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision: v3.3.4 updated in the page footer, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s Locations section is expanded with numerous US and Canadian sites, and the revision marker updated to v3.3.3.SummaryDifference2%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.